Neuroprotective approaches in experimental models of β-amyloid neurotoxicity: Relevance to Alzheimer's disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 23, Issue 6, 1999, Pages 963-1008

  Harkany, Tibor ^a,b,e   Hortobágyi, Tibor ^c   Sasvári, Maria ^a,b   Kónya, Csaba ^b   Penke, Botond ^d   Luiten, Paul G M ^e   Nyakas, Csaba ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Trace Element Research Center   (Hungary)

^c NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Amyloid; Calcium; N methyl D aspartate receptor; Neuroprotection; Oxidative stress

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ASCORBIC ACID; CALCIUM; CORTICOSTERONE; DIZOCILPINE; FREE RADICAL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NIMODIPINE; STEROID HORMONE; TRACE METAL;

ALZHEIMER DISEASE; ANIMAL MODEL; CALCIUM HOMEOSTASIS; CELL ENERGY; EXPERIMENTAL MODEL; LIPID PEROXIDATION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; RECEPTOR BINDING; REVIEW; SEQUENCE HOMOLOGY; TRANSGENIC ANIMAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 0033180601     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(99)00058-5     Document Type: Review

References (175)

1. Abe, E., Casamenti, F., Giovannelli, L., Scali, C. and Pepeu, G. (1994) Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res. 636: 162-164.
2. Ábrahám, I., Harkany, T., Sasvari, M., Jost, K., Zarándi, M., Penke, B., Bohus, B.G.J., Luiten, P.G.M. and Nyakas, C. (1998) Chronic Corticosterone Administration Dose-dependently Regulates β-amyloid and NMDA-induced Cholinotoxicity in Rat Magnocellular Nucleus Basalis. submitted.
3. Ábrahám, I., Veenema, A.H., Nyakas, C., Harkany, T., Bohus, B.G.J. and Luiten, P.G.M. (1997) Effect of corticosterone and adrenalectomy on NMDA-induced cholinergic cell death in rat magnocellular nucleus basalis. J. Neuroendocrinol. 9: 713-720.
4. Ames, B.N., Shigenaga, M.K. and Hagen, T.M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U.S.A. 90: 7915-7922.
5. Akama, K.T., Albanese, C., Pestell, R.G. and Van Eldik, L.J. (1998) Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NF-κB-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 95: 5795-5800.
6. 2+ interaction with Alzheimer amyloid β protein calcium channels. Proc. Natl. Acad. Sci. U.S.A. 93: 1710-1715.
7. Arispe, N., Rojas, E. and Pollard, H.B. (1993) Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. U.S.A. 90: 567-571.
8. Atwood, C.S., Moir, R.D., Huang, X., Scarpa, R.C., Bacarra, N.M., Romano, D.M., Hartshorn, M.A., Tanzi, R.E. and Bush, A.I. (1998) Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273: 12817-12826.
9. Auld, D.S., Karr, S. and Quirion, R. (1998) β-amyloid peptides as direct cholinergic neuromodulators: A missing link? Trends Neurosci. 21: 43-49.
10. Banks, W.A., Kastin, A.J., Maness, L.M., Banks, M.F., Shayo, M. and McLay, R.N. (1997) Interactions of β-amyloids with the blood-brain barrier. Ann. N.Y. Acad. Sci. 826: 190-199.
11. 2+ accumulation. Proc. Natl Acad. Sci. U.S.A. 92: 9328-9332.
12. Barth, A., Barth, L. and Newell, D.W. (1996) Combination therapy with MK-801 and α-tert-butyl-nitrone enhances protection against ischemic neuronal damage in organotypic hippocampal slice cultures. Exp. Neurol. 141: 330-336.
13. Bartus, R.T., Dean, R.L.III., Beer, B. and Lippa, S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-414.
14. Behl, C. (1997) Amyloid β-protein toxicity and oxidative stress in Azheimer's disease. Cell Tissue Res. 290: 471-480.
15. Behl, C., Davis, J., Cole, G.M. and Schubert, D. (1992) Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186: 944-952.
16. Behl, C., Davis, J.B., Klier, F.G. and Schubert, D. (1994a) Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645: 253-264.
17. Behl, C., Davis, J.B., Lesley, R. and Schubert, D (1994b) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77: 817-822.
18. Behl, C., Skutella, T., Lezoualc'h, F., Post, A., Widmann, M., Newton, C.J. and Holsboer, F. (1997) Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol. Pharmacol. 51: 535-541.
19. Bliss, T.V.P. and Collingridge, G.L. (1993) A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361: 31-39.
20. Braak H. and Braak, E. (1997) Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol. Aging 18 (Suppl. 4): S85-S88.
21. Castano, E.M. and Frangione, B. (1995) Non-Alzheimer's disease amyloidoses of the nervous system. Curr. Opin. Neurobiol. 8: 279-285.
22. Castano, E.M., Prelli, F., Soto, C., Beavis, R., Matsubara, E., Shoji, M. and Frangione, B. (1996) The length of amyloid-β in hereditary cerebral hemorrhage with amyloidosis, dutch type. Implications for the role of amyloid-β 1-42 in Alzheimer's disease. J. Biol. Chem. 271: 32185-32191.
23. Checler, F. (1995) Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65: 1431-1444.
24. Clemens, J.A. and Stephenson, D.T. (1992) Implants containing β-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol. Aging 13: 581-586.
25. 3H]MK-801 binding to rat cortical membranes. Neuroreport 5: 405-408.
26. Cowburn, R.F., Wiehager, B. and Sundström, E. (1995) β-amyloid peptides enhance binding of the calcium mobilising second messengers, inositol(l,4,5)triphosphate and inositol(l,3,4,5)tetrakisphosphate to their receptor sites in rat cortical membranes. Neurosci. Lett. 191: 31-34.
27. Cowburn, R.F., Wiehager, B., Trief, E., Li Li, M. and Sundström, E. (1997) Effects of β-amyloid(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: Evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor. Neurochem. Res. 22: 1437-1442.
28. Cuajungco, M.P. and Lees, G.J. (1997) Zinc metabolism in the brain: Relevance to human neurodegenerative disorders. Neurobiol. Dis. 4: 137-169.
29. De La Torre, M.R., Casado, A., Lopez-Fernandez, M.E., Carrascosa, D., Casado, M.C., Venarucci, D. and Venarucci, V. (1996) Human aging brain disorders: Role of antioxidant enzymes. Neurochem. Res. 21: 885-888.
30. Delobette, S., Privat, A. and Maurice, T. (1997) In vitro aggregation facilitates β-amyloid peptide-(25-35)-induced amnesia in the rat. Eur. J. Pharmacol. 319: 1-4.
31. De Strooper, B., Van Leuven, F. and Van Den Berghe, H. (1991) The amyloid β protein precursor or protease nexin II from mouse is closer related to its human homolog than previously reported. Biochim. Biophys. Acta 1129: 141-143.
32. Dutrait, N., Culcasi, M., Cazavieille, C., Pietri, S., Tordo, P., Bonne, C and Muller, A. (1995) Calcium-dependent free radical generation in cultured retinal neurons induced by kainate. Neurosci. Lett. 198: 13-16.
33. Emre, M., Geula, C., Ransil, B.J. and Mesulam, M.M. (1992) The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain. Neurobiol. Aging 13: 553-559.
34. Flood, J.F., Morley, J.E. and Roberts, E. (1991) Amnestic effects in mice of four synthetic peptides homologus to amyloid β protein from patients with Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 88: 3363-3366.
35. Flood, J.F., Morley, J.E. and Roberts, E. (1994a) An amyloid β-protein fragment, Aβ[12-28], equipotently impairs post-training memory processing when injected into different limbic system structures. Brain Res. 663: 271-276.
36. Flood, J.F., Roberts, E., Sherman, M.A., Kaplan, B.E. and Morley, J.E. (1994b) Topography of a binding site for small amnestic peptides deduced from structure-activity studies: Relation to amnestic effect of amyloid β protein. Proc. Natl. Acad. Sci. U.S.A. 91: 380-384.
37. Forloni, G., Tagliavini, F., Bugiani, O. and Salmona, M. (1996) Amyloid in Alzheimer's disease and prion-related encephalopathies: Studies with synthetic peptides. Prog. Neurobiol. 49:287-315.
38. Forloni, G., Lucca, E., Angeretti, N., Della Torre, P. and Salmona, M. (1997) Amidation of β-amyloid peptide strongly reduced the amyloidogenic activity without alteration of the neurotoxicity. J. Neurochem. 69: 2048-2054.
39. Frautschy, S.A., Baird, A. and Cole, G.M. (1991) Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. U.S.A. 88: 8362-8366.
40. Frölich L. and Riederer P. (1995) Free radical mechanisms in dementia of Alzheimer type and the potential of antioxidative treatment. Arzneimittelforschung 45: 443-446.
41. Furuta, A., Price, D.L., Pardo, C.A., Troncoso, J.C, Xu, Z.S., Taniguchi, N., Martin, L.J. (1995) Localization of superoxide dismutases in Alzheimer's disease and down's syndrome neocortex and hippocampus. Am. J. Pathol. 146: 357-367.
42. Games, D., Khan, K.M., Soriano, F.G., Keim, P.S., Davis, D.L., Bryant, K. and Lieberburg, I. (1992) Lack of Alzheimer pathology after β-amyloid protein injections in rat brain. Neurobiol. Aging 13: 569-576.
43. Garzuly, F., Vidal, R., Wisniewski, T., Brittig, F. and Budka, H. (1996) Familial meningocerebrovascular amyloidosis, hungarian type, with mutant transthyretin. Neurology 47: 1562-1567.
44. Geula, C, Wu, C.K., Saroff, D., Lorenzo, A., Yuan, M. and Yankner, B.A. (1998) Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nature Med 4: 827-831.
45. Ghanta, J., Shen, C.L., Kiessling, L.L. and Murphy, R.M. (1996) A strategy for designing inhibitors of β-amyloid toxicity. J. Biol. Chem. 271: 29525-29528.
46. Gilchrest, B.A. and Bohr, V.A. (1997) Aging processes, DNA damage, and repair. FASEB J. 11: 322-330.
47. Giovannelli, L., Casamenti, F., Scali, C., Bartolini, L. and Pepeu, G. (1995) Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience 66: 781-792.
48. Giovannelli, L., Scali, C., Faussone-Pellegrini, M.S., Pepeu, G. and Casamenti, F. (1998) Long-term changes in the aggregation state and toxic effects of β-amyloid injected into the rat brain. Neuroscience 87: 349-357.
49. Glenner, G.G. and Wong, C.W. (1984a) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890.
50. Glenner, G.G. and Wong, C.W. (1984b) Alzheimer's disease and down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122: 1131-1135.
51. Goodman, Y., Bruce, A.J., Cheng, B. and Mattson, M.P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66: 1836-1844.
52. + channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity. Brain Res. 706: 328-332.
53. Gray, C.W. and PateL, A.J. (1995) Neurodegeneration mediated by glutamate and β-amyloid peptide: A comparison and possible interaction. Brain Res. 691: 169-179.
54. Green, P.S., Gridley, K.E. and Simpkins, J.W. (1996) Estradiol protects β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218: 165-168.
55. Gridley, K.E., Green, P.S. and Simpkins, J.W. (1997) Low concentrations of estradiol reduce β-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res. 778: 158-165.
56. Griffin, W.S., Sheng, J.G., Royston, M.C., Gentleman, S.M., McKenzie, J.E., Graham, D.I., Roberts, G.W. and Mrak, R.E. (1998) Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8: 65-72.
57. Gwebu, E.T., Williams, J., Mathis, D., Warden, J.A., Selassie, M., Richardson, S., Gwebu, N.T. (1997) Cytotoxicity of β-amyloid peptide 25-35 on vascular smooth muscle cells and attenuation by vitamin E. In Vitro Cell Dev. Biol. Anim. 33: 672-673.
58. Haass, C., Hung, A.J., Schlossmacher, M.G., Oltersdorf, T., Teplow, D.B. and Selkoe, D.J. (1993) Normal cellular processing of the β-amyloid precursor protein results in the secretion of the amyloid β peptide and related molecules. Ann. N.Y. Acad. Sci. 695: 109-116.
59. Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A, Ostaszewski, B.L., Lieberburg, I., Koo, E.H., Schenk, D., Teplow, D.B., Selkoe, D.J. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325.
60. Haass, C. and Selkoe, D.J. (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75: 1039-1042.
61. Halliwell, B. (1987) Oxidants and human disease: Some new concepts. FASEB J. 1: 358-364.
62. Harkany, T., Ábrahám, I., Laskay, G., Timmerman, W., Jost, K., Zarándi, M., Penke, B., Nyakas, C. and Luiten, P.G.M. (1999) Propionyl-IIGL tetrapeptide prevents β-amyloid excitotoxicity in rat nucleus basalis. Neuroreport, in press.
63. 2+-mediated mechanisms of β-amyloid-induced brain injury. Soc. Neurosci. Abstr. 23: 1627.
64. (1-42) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat. Brain Res. 698: 270-274.
65. (1-42) peptide on cortical projections of the rat nucleus basalis magnocellularis. Brain Res. 685: 71-75.
66. 2+ entry blockade and radical scavengers protect cholinergic nucleus basalis neurons against β-amyloid neurotoxicity. Neurobiol. Dis., in press.
67. 24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation. Behav. Brain. Res. 90: 133-145.
68. Harkany, T., Sasvári, M., Vinczer, P., Kónya, C. and Nyakas, C. (1998c) Neuroprotection by a complex containing trace metals and vitamins against anoxia-induced free radical generation and brain injury in the rat: Comparison with the effects of vitamin E administration. Clin. Neurosci. 51, Suppl. 1: 39-40.
69. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J. Neurochem. 67: 277-286.
70. Hartmann, H., Eckert, A. and Müller, W.E. (1994) Apolipoprotein E and cholesterol affect neuronal calcium signalling: The possible relationship to β-amyloid neurotoxicity. Biochem. Biophys. Res. Commun. 200: 1185-1192.
71. Hensley, K., Carney, J.M., Mattson, M.P., Aksenova, M., Harris, M., Wu, J.F., Floyd, R.A. and Butterfield, D.A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 91: 3270-3274.
72. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L. and Beyreuther, K. (1991) Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. Mol. Biol. 218: 149-163.
73. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L. and Beyreuther, K. (1992) Substitutions of hydrophobic amino acids reduce the amyloidogenity of Alzheimer's disease βA4 peptides. J. Mol. Biol. 228: 460-473.
74. Huang, X., Atwood, C.S., Moir, R.D., Hartshorn, M.A., Vonsattel, J.P., Tanzi, R.E. and Bush, A.I. (1997) Zinc-induced Alzheimer's Aβ1-40 aggregation is mediated by conformational factors. J. Biol. Chem. 272: 26464-26470.
75. Ishkawa, H., Ozawa, H., Saito, T., Takahata, N. and Takemura, H. (1998) Calcium mobilization evoked by amyloid β-protein involves inositol 1,4,5-triphosphate production in human platalets. Life Sci. 62: 705-713.
76. Itoh, A, Nitta, A., Nadai, M., Nishimura, K., Hirose, M., Hasegawa, T. and Nabeshjma, T. (1996) Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J. Neurochem. 66: 1113-1117.
77. Jaffe, A.B., Toran-Allerand, C.D., Greengard, P. and Gandy, S.E (1994) Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 269:13065-13068.
78. Jancsó, G., Domoki, F., Sántha, P., Varga, J.L., Fischer, J., Orosz, K., Penke, B., Becskei, A., Dux, M. and Tóth, L. (1998) β-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats. Neurosci. Lett. in press.
79. Joels, M. (1997) Steroid hormons and excitability in the mammalian brain. Front. Neuroendocrinol. 18: 2-48.
80. Johnstone, E.M., Chaney, M.O., Norris, F.H., Pascual, R. and Little, S.P. (1991) Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Mol. Brain Res. 10: 299-305.
81. Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P.A. and Kaltschmidt, C. (1997) Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94: 2642-2647.
82. Kang, J., Lemaire, H.G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.H., Multhaup, G., Beyreuther, K and Müller-Hill, B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
83. 2+-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. Biophys. J. 73: 67-75.
84. +-ATPase activity, glucose transport, and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res. 50: 522-530.
85. Keller, J.N. and Mattson, M.P. (1998) Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev. Neurosci. 9: 105-116.
86. Kimura, H. and Schubert, D. (1993) Amyloid β-protein activates tachykinin receptors and inositol triphosphate accumulation by synergy with glutamate. Proc. Natl. Acad. Sci. U.S.A. 90: 7508-7512.
87. Koh, J., Yang, L.L. and Cotman, C.W. (1990) β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533: 315-320.
88. Koppal, T., Subramaniam, R., Drake, J., Prasad, M.R., Dhillon, H. and Butterfield, D.A. (1998) Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition. Brain Res. 786: 270-273.
89. Korenberg, J.R., Pulst, S.M., Neve, R.L. and West, R. (1989) The Alzheimer amyloid precursor protein maps to human chromosome 21 bands q21.105-q21.05. Genomics 5: 124-127.
90. nd Ed. John Wiley and Sons, pp 145.
91. Kowall, N.W., Beal, M.F., Busciglio, J., Duffy, L.K. and Yankner, B.A. (1991) An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. U.S.A. 88: 7247-7251.
92. 2+]i in rat astrocytes. Biochem. Biophys. Res. Commun. 235: 479-481.
93. Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.L., Wals, P., Zhan G, C., Finch, C.E, Krafft, G.A. and Klein, W.L. (1998) Diffusible, nonfibrillar ligands derived from Aβ 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95: 6448-6453.
94. Lezoualc'h, F., Sagara, Y., Holsboer, F. and Behl, C. (1998) High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18: 3224-3232.
95. 2+ antagonist nimodipine, influence of aging and developmental drug treatment. Neurodegeneration 4: 307-314.
96. Luiten, P.G.M., Gaykema, R.P.A., Traber, J. and Spencer, D.G. Jr. (1987) Cortical projection patterns of magnocellular basal nucleus subdivisions as revealed by anterogradely transported Phaseolus vulgaris leucoagglutinin. Brain Res. 413: 229-250.
97. Luiten, P.G.M., Stuiver, B.T., De Jong, G.I., Nyakas, C. and De Keyser, J.H.A. (1996) Calcium homeostasis, nimodipine and stroke. In: Clinical Pharmacology of Cerebral Ischemia G.J. Ter Horst and J. Korf (Eds.), pp 67-99, Humana Press, Totowa.
98. Mackic, J.B., Stins, M., McComb, J.G., Calero, M, Ghiso, J., Kim, K.S., Yan, D.S., Stern, D., Schmidt, Am., Frangione, B. and Zlokovic, B.V. (1998a) Human blood-brain barrier receptors for Alzheimer's amyloid-β 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J. Clin. Invest. 102. 734-743.
99. Mackic, J.B., Weiss, M.H., Miao, W., Kirkman, E., Ghiso, J., Calero, M., Bading, J., Frangione, B. and Zlokovic, B.V. (1998b) Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid β peptide in aged squirrel monkey with cerebral amyloid angiopathy. J. Neurochem. 70: 210-215.
100. 2+ deregulation, and cytosceletal pathology. Neurobiol. Aging 16: 187-198.
101. +-ATPase activity in hippocampal neurons. Brain Res. 756: 205-214.
102. Mark, R.J., Lovell, M.A., Markesbery, W.R., Uchida, K. and Mattson, M.P. (1997b) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68: 255-264.
103. Markesbery, W.R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23: 134-147.
104. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L. and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer's disease and down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82: 4245-4249.
105. Mattson, M.P. (1994) Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25: 439-450.
106. Mattson, M.P. (1995) Free radicals and disruption of neuronal ion homeostasis in AD: A role for amyloid β-peptide? Neurobiol. Aging. 16: 679-682.
107. Mattson, M.P. (1998) Modification of ion homeostasis by lipid peroxidation: Roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21.: 53-57.
108. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R.E. (1992) β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12: 376-389.
109. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem, 65: 1740-1751.
110. Mattson, M.P., Rychlik, B., Chu, C. and Christakos, S. (1991) Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 6: 41-51.
111. Mattson, M.P., Tomaselli, K.J. and Rydel, R.E. (1993) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621: 36-49.
112. Maurice, T., Lockhart, B.P., Su, T.P. and Privat, A. (1996) Reversion of β 25-35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists. Brain Res. 731: 249-253.
113. McGeer, E.G. and McGeer, P.L. (1998) The importance of inflammatory mechanisms in Alzheimer disease. Brain Pathol. 33: 371-378.
114. McGeer, P.L., Walker, D.G., Akiyama, H., Yasuhara, O. and McGeer, E.G. (1994) Involvement of microglia in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 20: 191-192.
115. McKee, A.C., Kowall, N.W., Schumacher, J.S. and Beal, M.F. (1998) The neurotoxicity of amyloid β protein in aged primates. Amyloid 5:1-9.
116. Mecocci, P., Macgarvey, U. and Beal, M.F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36: 747-750.
117. Mirzabekov, T., Lin, M.C., Yuan, W.L., Marshall, P.J., Carman, M., Tomaselli, K., Lieberburg, I. and Kagan, B.L. (1994) Channel formation in planar bilayers by a neurotoxic fragment of the β-amyloid peptide. Biochem. Biophys. Res. Commun. 202: 1142-1148.
118. 2+] in hippocampal neurons. Neuroreport 9: 1553-1558.
119. Mook-Jung, I., Joo, I., Sohn, S., Kwon, H.J., Huh, K. and Jung, M.W. (1997) Estrogen blocks neurotoxic effects of β-amyloid (1-42) and induces neurite extension on B103 cells. Neurosci. Lett. 235: 101-104.
120. Morimoto, K., Yoshimi, K., Tonohiro, T., Yamada, N., Oda, T. and Kaneko, I. (1998a) Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons. Neuroscience 84: 479-487.
121. Morimoto, T., Ohsawa, I., Takamura, C., Ishiguro, M. and Kohsaka, S. (1998b) Involvement of amyloid precursor protein in functional synapse formation in cultured hippocampal neurons. J. Neurosci. Res. 51: 185-195.
122. Moya, K.L., Benowitz, L.I., Schneider, G.E. and Allinquant, B. (1994) The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis. Dev. Biol. 161: 597-603.
123. Multhaup, G., Ruppert, T., Schlicksupp, A., Hesse, L., Beher, D., Masters, C.L. and Beyreuther, K. (1997) Reactive oxygen species in Alzheimer's disease. Biochem. Pharmacol. 54: 533-539.
124. 0. Nature 362: 75-79.
125. Nitta, A., Fukuta, T., Hasegawa, T. and Nabeshima, T. (1997) Continuous infusion of β-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn. J. Pharmacol. 73: 51-57.
126. Nitta, A., Itoh, A., Hasegawa, T. and Nabeshima, T. (1994) β-amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170: 63-66.
127. Okado, H. and Okamoto, H. (1992) A xenopus homologue of the human β-amyloid precursor protein: Developmental regulation of its gene expression. Biochem. Biophys. Res. Commun. 189: 1561-1568.
128. O'Mahony, S., Harkany, T., Rensink, A.A.M., Ábrahám, I., De Jong, G.I., Varga, J.L., Zarándi, M., Penke, B., Nyakas, C., Luiten, P.G.M. and Leonard, B.E. (1998) β-amyloid-induced cholinergic denervation correlates with enhanced nitric oxide synthase activity in rat cerebral cortex: Reversal by NMDA receptor blockade. Brain Res. Bull. 45: 405-411.
129. O'Neill, L.A.J. and Kaltschmidt, C. (1997) NF-κB: A crucial transcription factor for glial and neuronal function. Trends Neurosci. 20: 252-258.
130. 1a receptor agonist 8-OH-DPAT. Eur. J. Pharmacol. 358: 147-152.
131. Paganini-Hill, A. and Henderson, V.W. (1996) Estrogen replacement therapy and risk of Alzheimer disease. Arch. Intern. Med. 156: 2213-2217.
132. Pike, C., Burdick, D., Walencewicz, A., Glabe, C. and Cotman, C.W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13: 1676-1687.
133. Pike, C.J. and Cotman, C.W. (1993) Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid. Neuroscience 56: 269-274.
134. Pike, C.J. and Cotman, C.W. (1995) Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vitro. Brain Res. 671: 293-298.
135. Pike, C.J., Ramezan-Arab, N. and Cotman, C.W. (1997) β-amyloid neurotoxicity in vitro: Evidence of oxidative stress but not protection by antioxidants. J. Neurochem. 69: 1601-1611.
136. Pitschke, M., Prior, R., Haupt, M. and Riesner, D. (1998) Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy. Nat. Med. 4: 832-834.
137. Pluta, R., Misicka, A., Januszewski, S., Barcikowska, M. and Lipkowski. A.W. (1997) Transport of human β-amyloid peptide through the rat blood-brain barrier after global cerebral ischemia. Acta Neurochir. Suppl. Wien. 70: 247-249.
138. Podlisny, M.B., Stephenson, D.T., Frosch, M.P., Tolan, D.R., Lieberburg, I., Clemens, J.A. and Selkoe, D.J. (1993) Microinjection of synthetic amyloid β-protein in monkey cerebral cortex fails to produce acute neurotoxicity. Am. J. Pathol. 142: 17-24.
139. Rogers, J. (1995) Inflammation as a pathogenic mechanism in Alzheimer's disease. Arzneimittelforschung 45: 439-442.
140. Rush, D.K., Aschmies, S. and Merriman, M.C. (1992) Intracerebral β-amyloid(25-35) produces tissue damage: Is it neurotoxic? Neurobiol. Aging 13: 591-594.
141. 125i-labeled β-amyloid peptide Aβ 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the Aβ1-40/vector complex. Proc. Natl. Acad. Sci. U.S.A. 92: 10227-10231.
142. Shea, T.B., Prabhakar, S. and Ekinci, F.J. (1997) β-amyloid and ionophore A23187 evoke tau hyperphosphorylation by distinct intracellular pathways: Differential involvement of the calpain/protein kinase C system. J. Neurosci. Res. 49: 759-768.
143. Selkoe, D.J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487-498.
144. Shin, R.W., Ogino, K., Kondo, A., Saido, T.C, Trojanowski, J.Q., Kitamoto, T. and Tateishi J. (1997) Amyloid β-protein (Aβ) 1-40 but not Aβ1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrills in rat brain. J. Neurosci. 17: 8187-8193.
145. Sisodia, S.S., Koo, E.H., Beyreuther, K., Unterbeck, A. and Price, D.L. (1990) Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-495.
146. Schliebs, R., Rossner, S. and Biegl, V. (1996) Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: A useful tool to produce cortical cholinergic dysfunction. Prog. Brain Res. 109: 253-264.
147. Smith, M.A., Sayre, L.M., Monnier, V.M. and Perry, G. (1995) Radical ageing in Alzheimer's disease. Trends Neurosci. 18: 172-176.
148. Solomon, B., Koppel, R., Frankel, D. and Hanan-Aharon, E. (1997) Disaggregation of Alzheimer β-amyloid by site-directed mAb. Proc. Natl. Acad. Sci. U.S.A. 94: 4109-4112.
149. Soto, C, Sigurdsson, E.M., Morelli, L., Kumar, R.A., Castano, E.M. and Frangione, B. (1998) β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy. Nat. Med. 4: 822-826.
150. Snyder, S.W., Ladror, U.S., Wade, W.S., Wang, W.S., Wang, G.T., Barrett, L.W., Matayoshi, E.D., Huffaker, H.J., Krafft, G.A. and Holzman, T.F. (1994) Amyloid-β aggregation: Selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67: 1216-1228.
151. Stadtman, E.R. and Oliver, C.N. (1991) Metal-catalyzed oxidation of proteins. J. Biol. Chem. 266: 2005-2008.
152. Stein-Behrens, B., Adams, K., Yeh, M. and Sapolsky, R. (1992) Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat. Neurobiol. Aging. 13: 577-579.
153. 2+ levels in cultured rat astrocytes. Neurosci. Lett. 243: 121-124.
154. Stuiver, B.T., Douma, B.R.K., Barker, R., Nyakas, C. and Luiten, P.G.M. (1996) In vivo neuroprotection against NMDA-induced neurodegeneration by MK-801 and nimodipine: Combined therapy and temporal course of protection. Neurodegeneration 5: 153-159.
155. Stuiver, B.T., Stienstra, C.M., Oosterink, B.J., Nyakas, C. and Luiten, P.G.M. (1997) Combined therapy with 8-OH-DPAT and nimodipine against in vivo NMDA-induced cell death in rat nucleus basalis. In: Neurochemistry, A.W. Teelken and J. Korf (Eds.), pp 351-355, Plenum Press, New York.
156. Suo, Z., Fang, C., Crawford, F., Mullan, M. (1997) Superoxide free radical and intracellular calcium mediate Aβ1-42 induced endothelial toxicity. Brain Res. 762: 144-152.
157. Tjernberg, L.O., Naslund, J., Lindquist, F, Johansson, J., Karlstrom, A.R., Thyberg, J., Terenius, L. and Norstedt, C. (1996) Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271: 8545-8548.
158. Tomiyama, T., Shoji, A., Kataoka, K., Suwa, Y., Asano, S., Kaneki, H. and Endo, N. (1996) Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 271: 6839-6844.
159. 2+ channels: A possible involvement of free radicals. J. Neurochem 68: 265-271.
160. Velazquez, P., Cribbs, D.H., Poulos, T.L. and Tenner, A.J. (1997) Aspartate residue 7 in amyloid β-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis. Nat. Med. 3: 77-79.
161. Vidal, R, Garzuly, F., Budka, H., Lalowski, M, Linke, R.P., Brittig, F., Frangione, B. and Wisniewski, T. (1996) Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18. Am. J. Pathol 148: 361-366.
162. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62: 372-375.
163. Whiston, J.S. and Appel, S.H. (1995) Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade. Neurobiol. Aging 16: 5-10.
164. Whiston, J.S, Selkoe, D.J. and Cotman, C.W. (1989) Amyloid β protein enhances the survival of hippocampal neurons in vitro. Science 243: 1488-1490.
165. Winkler, J., Connor, D.J., Frautschy, S.A., Behl, C, Waite, J.J., Cole, G.M. and Thal, L.J. (1994) Lack of long-term effects after β-amyloid protein injections in rat brain. Neurobiol. Aging 15: 601-607.
166. Wood, S.J, Mackenzie, L, Maleeff, B., Hurle, Mr. and Wetzel, R. (1996) Selective inhibition of Aβ fibril formation. J. Biol. Chem. 271: 4086-4092.
167. Xu, H., Gouas, O.K., Greenfield, J.P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Jovanovic, J.N., Seeger, M, Relkin, N.R., Liao, F, Checler, F., Buxbaum, J.D., Chait, B.T., Thinakaran, G., Sisodia, S.S., Wang, R., Greengard, P. and Gandy, S. (1998) Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat. Med. 4: 447-451.
168. Yallampalli, S., Micci, M.A. and Taglialatela, G. (1998) Ascorbic acid prevents β-amyloid-induced intracellular calcium increase and cell death in PC12 cells. Neurosci. Lett. 251: 105-108.
169. Yamada, K., Nitta, A., Saito, T., Hu, J. and Nabeshima, T. (1995) Changes in cilicary neurotrophic factor content in the rat brain after continuous intracerebroventricular infusion of β-amyloid(1-40) protein. Neurosci. Lett. 201: 155-158.
170. Yamada, K., Tanaka, T., Senzaki, K., Kameyama, T. and Nabeshima, T. (1998) Propentofylline improves learning and memory deficits in rats induced by β-amyloid protein-(1-40). Eur. J. Pharmacol. 349: 15-22.
171. Yamada, T., Sasaki, H., Furuya, H., Miyata, T., Goto, I. and Sakaki, Y. (1987) Complementary DNA for the mouse homolog of the human amyloid beta protein precursor. Biochem. Biophys. Res. Commun. 149: 665-671.
172. Yan, S.D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D. and Schmidt, A.M. (1996) Rage and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
173. Yan, S.D., Zhu, H., Fu, J., Yan, S.F., Roher, A., Tourtellotte, W.W., Rajavashisth, T., Chen, X., Godman, G.G., Stern, D. and Schmidt, A.M. (1997) Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94: 5296-5301.
174. Yankner, B.A., Dawes, L.R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M.L. and Neve, R.L. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245: 427-429.
175. Yankner, B.A., Duffy, L.K. And Kirschner, D.A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250: 279-282.